Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hatsukami

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Journal of Clinical Psychopharmacology|August 1, 1989
Response to alternative antidepressants in imipramine nonresponders with bulimia nervosaJ E Mitchell, R L Pyle, E D Eckert, et al.
Biological Psychiatry|January 1, 1987
High-dose naltrexone therapy and dietary counseling for obesityJ E Mitchell, J E Morley, A S Levine, et al.
The American Journal of Psychiatry|July 1, 1990
Maintenance treatment and 6-month outcome for bulimic patients who respond to initial treatmentR L Pyle, J E Mitchell, E D Eckert, et al.
Archives of General Psychiatry|February 1, 1990
A comparison study of antidepressants and structured intensive group psychotherapy in the treatment of bulimia nervosaJ E Mitchell, R L Pyle, E D Eckert, et al.
Psychopharmacology|March 13, 1998
Cotinine: effects with and without nicotineD Hatsukami, P R Pentel, J Jensen, et al.
Psychopharmacology|July 24, 1998
Effects of dynorphin A(1-13) on opiate withdrawal in humansS Specker, W Wananukul, D Hatsukami, et al.
American Journal of Public Health|September 1, 1992
Smoking cessation in women concerned about weightP L Pirie, C M McBride, W Hellerstedt, et al.
Pharmacology, Biochemistry, and Behavior|June 1, 1995
Effects of high intravenous doses of dynorphin A(1-13) on tail flick latency and central nervous system histology in ratsP R Pentel, W Wananukul, L P Hooke, et al.
Drug and Alcohol Dependence|June 18, 2014
Scientific overview: 2013 BBC plenary symposium on tobacco addictionM De Biasi, I McLaughlin, E E Perez, et al.
Psychological Medicine|July 24, 2014
Smoking cessation is associated with lower rates of mood/anxiety and alcohol use disordersP A Cavazos-Rehg, N Breslau, D Hatsukami, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Journal of Clinical Psychopharmacology|August 1, 1989
Response to alternative antidepressants in imipramine nonresponders with bulimia nervosaJ E Mitchell, R L Pyle, E D Eckert, et al.
Biological Psychiatry|January 1, 1987
High-dose naltrexone therapy and dietary counseling for obesityJ E Mitchell, J E Morley, A S Levine, et al.
The American Journal of Psychiatry|July 1, 1990
Maintenance treatment and 6-month outcome for bulimic patients who respond to initial treatmentR L Pyle, J E Mitchell, E D Eckert, et al.
Archives of General Psychiatry|February 1, 1990
A comparison study of antidepressants and structured intensive group psychotherapy in the treatment of bulimia nervosaJ E Mitchell, R L Pyle, E D Eckert, et al.
Psychopharmacology|March 13, 1998
Cotinine: effects with and without nicotineD Hatsukami, P R Pentel, J Jensen, et al.
Psychopharmacology|July 24, 1998
Effects of dynorphin A(1-13) on opiate withdrawal in humansS Specker, W Wananukul, D Hatsukami, et al.
American Journal of Public Health|September 1, 1992
Smoking cessation in women concerned about weightP L Pirie, C M McBride, W Hellerstedt, et al.
Pharmacology, Biochemistry, and Behavior|June 1, 1995
Effects of high intravenous doses of dynorphin A(1-13) on tail flick latency and central nervous system histology in ratsP R Pentel, W Wananukul, L P Hooke, et al.
Drug and Alcohol Dependence|June 18, 2014
Scientific overview: 2013 BBC plenary symposium on tobacco addictionM De Biasi, I McLaughlin, E E Perez, et al.
Psychological Medicine|July 24, 2014
Smoking cessation is associated with lower rates of mood/anxiety and alcohol use disordersP A Cavazos-Rehg, N Breslau, D Hatsukami, et al.
Pageof 7